Cargando…
Expression of AKT1 Related with Clinicopathological Parameters in Clear Cell Renal Cell Carcinoma
Pathways such as VEGF, EGF and mTOR are known to be one of the major mechanisms of tumorigenesis including kidney cancer. To identify potential signaling pathway proteins, we performed differential/correlation analyses of mTOR-associated genes from three public datasets. AKT1 protein, one of the PI3...
Autores principales: | Choi, Taesoo, Yoo, Koo Han, Kim, Man S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600081/ https://www.ncbi.nlm.nih.gov/pubmed/36286049 http://dx.doi.org/10.3390/cimb44100334 |
Ejemplares similares
-
Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma
por: YOO, KOO HAN, et al.
Publicado: (2014) -
Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review
por: Kim, Hyeong Su, et al.
Publicado: (2018) -
Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma
por: Kruck, Stephan, et al.
Publicado: (2013) -
Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma
por: Bi, Hai, et al.
Publicado: (2020) -
Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2021)